# Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

> **NCT01740414** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 28 (actual)

## Conditions studied

- Opioid Abuse
- Opioid Dependence

## Interventions

- **DRUG:** MN-166 (50 mg) First
- **DRUG:** Placebo First

## Key facts

- **NCT ID:** NCT01740414
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-12
- **Final completion:** 2017-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-08-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740414, "Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01740414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*